[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Wegro App @wegro_app on x 10.3K followers
Created: 2025-06-02 02:38:17 UTC
Zydus Lifesciences received tentative approval from the USFDA for Rifaximin Tablets, XXX mg. This is for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults. π The tablets will be produced at the Groupβs manufacturing site at SEZ II, Ahmedabad.
- ππ²π ππΆπ΄π΅πΉπΆπ΄π΅ππ: βͺ Tentative approval from USFDA for Rifaximin Tablets, XXX mg. βͺ Indicated for treating irritable bowel syndrome with diarrhea (IBS-D). βͺ Manufacturing to be done at Ahmedabad site. βͺ Rifaximin tablets had annual sales of USD $2672.9 million in the US (IQVIA MAT March 2025). βͺ The group has XXX approvals and has filed XXX ANDAs since FY 2003-04.
π ZYDUS LIFESCIENCES LTD | π·οΈ Press Release / Media Release
π Details:
β‘οΈAI-driven WhatsApp updates - Try FREE π
XXX engagements
Related Topics $mngl $zyduslifebo